Sidney Health Center Hospice Medicare Approved Location: 216 14th Ave Sw, Sidney, Montana 59270 Phone: (406) 488-2226 |
News Archive
New data presented at the EULAR meeting (European League Against Rheumatism) show for the first time that MabThera (rituximab), a unique B cell targeted therapy, is able to significantly inhibit structural damage of joints caused by rheumatoid arthritis (RA).
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
"Comparative Effectiveness will have the most significant impact on the orthopaedic industry moving forward," noted John Engelhardt in his luncheon Keynote Address today at the 6th Annual Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) in Chicago, Illinois. Mr. Engelhardt, CEO of ORTHOWORLD Inc. and Managing Member of Knowledge Ventures, LLC, emphasized that industry will be compelled to adopt the concept of comparative effectiveness throughout its business models in order to gain the efficiencies required to thrive in the future.
The most widely prescribed antidepressants - medicines such as Prozac, Lexapro and Paxil - work by blocking the serotonin transporter, a brain protein that normally clears away the mood-regulating chemical serotonin. Or so the current thinking goes.
› Verified 3 days ago